» Articles » PMID: 28191702

Hospitalizations, Costs and Outcomes Associated with Heroin and Prescription Opioid Overdoses in the United States 2001-12

Overview
Journal Addiction
Specialty Psychiatry
Date 2017 Feb 14
PMID 28191702
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The full burden of the opioid epidemic on US hospitals has not been described. We aimed to estimate how heroin (HOD) and prescription opioid (POD) overdose-associated admissions, costs, outcomes and patient characteristics have changed from 2001 to 2012.

Design: Retrospective cohort study of hospital admissions from the National Inpatient Sample (NIS).

Setting: United States of America.

Participants: Hospital admissions in patients aged 18 years or older admitted with a diagnosis of HOD or POD. The NIS sample included 94 492 438 admissions from 2001 to 2012. The final unweighted study sample included 138 610 admissions (POD: 122 147 and HOD: 16 463).

Measurements: Primary outcomes were rates of admissions per 100 000 people using US Census Bureau annual estimates. Other outcomes included in-patient mortality, hospital length-of-stay, cumulative and mean hospital costs and patient demographics. All analyses were weighted to provide national estimates.

Findings: Between 2001 and 2012, an estimated 663 715 POD and HOD admissions occurred nation-wide. HOD admissions increased 0.11 per 100 000 people per year [95% confidence interval (CI) = 0.04, 0.17], while POD admissions increased 1.25 per 100 000 people per year (95% CI = 1.15, 1.34). Total in-patient costs increased by $4.1 million dollars per year (95% CI = 2.7, 5.5) for HOD admissions and by $46.0 million dollars per year (95% CI = 43.1, 48.9) for POD admissions, with an associated increase in hospitalization costs to more than $700 million annually. The adjusted odds of death in the POD group declined modestly per year [odds ratio (OR) = 0.98, 95% CI = 0.97, 0.99], with no difference in HOD mortality or length-of-stay. Patients with POD were older, more likely to be female and more likely to be white compared with HOD patients.

Conclusions: Rates and costs of heroin and prescription opioid overdose related admissions in the United States increased substantially from 2001 to 2012. The rapid and ongoing rise in both numbers of hospitalizations and their costs suggests that the burden of POD may threaten the infrastructure and finances of US hospitals.

Citing Articles

What influences Australian pharmacists' decisions to supply opioids? Results from a survey and randomised controlled factorial experiment.

Picco L, Xia T, Laing R, Grist E, Dostal J, Nielsen S Drug Alcohol Rev. 2025; 44(3):783-792.

PMID: 39916423 PMC: 11886474. DOI: 10.1111/dar.14009.


Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.

Bobb J, Idu A, Qiu H, Yu O, Boudreau D, Wartko P Drug Alcohol Depend. 2024; 261:111350.

PMID: 38875880 PMC: 11281026. DOI: 10.1016/j.drugalcdep.2024.111350.


Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use disorder.

Bart G, Korthuis P, Donohue J, Hagedorn H, Gustafson D, Bazzi A Addict Sci Clin Pract. 2024; 19(1):29.

PMID: 38600571 PMC: 11007900. DOI: 10.1186/s13722-024-00455-9.


Identifying Prescription-Opioid-Related Risks Using Prescription Drug Monitoring Programs' Algorithms and Clinical Screening Tools.

Picco L, Jung M, Cangadis-Douglass H, Lam T, Nielsen S Pharmacy (Basel). 2023; 11(5).

PMID: 37888509 PMC: 10609676. DOI: 10.3390/pharmacy11050164.


Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.

Picco L, Xia T, Bell J, Pearce C, Buchbinder R, Lubman D Drug Alcohol Rev. 2023; 42(7):1639-1646.

PMID: 37798947 PMC: 10947011. DOI: 10.1111/dar.13754.


References
1.
Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View

2.
Hedegaard H, Chen L, Warner M . Drug-poisoning deaths involving heroin: United States, 2000-2013. NCHS Data Brief. 2015; (190):1-8. View

3.
Unick G, Rosenblum D, Mars S, Ciccarone D . Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One. 2013; 8(2):e54496. PMC: 3566161. DOI: 10.1371/journal.pone.0054496. View

4.
Slavova S, Bunn T, Talbert J . Drug overdose surveillance using hospital discharge data. Public Health Rep. 2014; 129(5):437-45. PMC: 4116371. DOI: 10.1177/003335491412900507. View

5.
Ronan M, Herzig S . Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002-12. Health Aff (Millwood). 2016; 35(5):832-7. PMC: 5240777. DOI: 10.1377/hlthaff.2015.1424. View